Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Clinical trial NCT06666270 · RECRUITING

Trial details

NCT number: NCT06666270
Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Cancer Metastatic Solid Tumor Ovarian Cancer Breast Cancer Prostate Cancer BRCA Mutation HRR Deficiency

Start date: 2024-11-21
Primary completion: 2026-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.